These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo. Zhang JT, Fan YZ, Chen CQ, Zhao ZM, Sun W. Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632 [Abstract] [Full Text] [Related]
3. [Anti-tumor mechanism of norcantharidin for the implanted tumors of human gallbladder carcinoma in nude mice in vivo]. Fan YZ, Zhao ZM, Fu JY, Chen CQ. Zhonghua Wai Ke Za Zhi; 2006 May 01; 44(9):618-22. PubMed ID: 16784656 [Abstract] [Full Text] [Related]
5. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins. Wada H, Nagano H, Yamamoto H, Arai I, Ota H, Nakamura M, Damdinsuren B, Noda T, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Doki Y, Dono K, Nakamori S, Sakon M, Monden M. Oncol Rep; 2007 Oct 01; 18(4):801-9. PubMed ID: 17786339 [Abstract] [Full Text] [Related]
6. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro. Fan YZ, Fu JY, Zhao ZM, Chen CQ. Hepatobiliary Pancreat Dis Int; 2007 Feb 01; 6(1):72-80. PubMed ID: 17287171 [Abstract] [Full Text] [Related]
7. Norcantharidin enhances TIMP‑2 anti‑vasculogenic mimicry activity for human gallbladder cancers through downregulating MMP‑2 and MT1‑MMP. Zhu W, Sun W, Zhang JT, Liu ZY, Li XP, Fan YZ. Int J Oncol; 2015 Feb 01; 46(2):627-40. PubMed ID: 25405519 [Abstract] [Full Text] [Related]
8. Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway. Zhang JT, Sun W, Zhang WZ, Ge CY, Liu ZY, Zhao ZM, Lu XS, Fan YZ. BMC Cancer; 2014 Mar 15; 14():193. PubMed ID: 24628713 [Abstract] [Full Text] [Related]
9. Influence of norcantharidin on proliferation, proliferation-related gene proteins proliferating cell nuclear antigen and Ki-67 of human gallbladder carcinoma GBC-SD cells. Fan YZ, Fu JY, Zhao ZM, Chen CQ. Hepatobiliary Pancreat Dis Int; 2004 Nov 15; 3(4):603-7. PubMed ID: 15567755 [Abstract] [Full Text] [Related]
10. [Study of the anti-tumor effect of anti-vascular endothelial growth factor McAb 5-fluorouracil loaded polylactic acid nanoparticles]. Huang KH, Liu JH, Wang LY, Zhu ZH, Chen QK, Min J, Chen RF. Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Sep 15; 10(5):482-5. PubMed ID: 17851795 [Abstract] [Full Text] [Related]
11. [Antitumor and anti-angiogenic effects of manumycin on human hepatocellular carcinoma HepG2 xenografts in nude mice]. Zhou JM, Zhu XF, Liu ZC, Fu LW, Yang XP, Liang YJ, Pan QC. Ai Zheng; 2005 Aug 15; 24(8):935-9. PubMed ID: 16086869 [Abstract] [Full Text] [Related]
12. [Effects of melittin on growth and angiogenesis of human hepatocellular carcinoma BEL-7402 cell xenografts in nude mice]. Song CC, Lu X, Cheng BB, DU J, Li B, Ling CQ. Ai Zheng; 2007 Dec 15; 26(12):1315-22. PubMed ID: 18076793 [Abstract] [Full Text] [Related]
13. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo. Li XP, Jing W, Sun JJ, Liu ZY, Zhang JT, Sun W, Zhu W, Fan YZ. BMC Cancer; 2015 Jul 19; 15():527. PubMed ID: 26187792 [Abstract] [Full Text] [Related]
14. Norcantharidin is a small-molecule synthetic compound with anti-angiogenesis effect. Chen YJ, Tsai YM, Kuo CD, Ku KL, Shie HS, Liao HF. Life Sci; 2009 Oct 21; 85(17-18):642-51. PubMed ID: 19765597 [Abstract] [Full Text] [Related]
15. [Up-regulation of thymidine phosphorylase and anti-angiogenesis by interferon alpha in human hepatocellular carcinoma cell line and xenograft]. Xiao YS, Zhou J, Tang ZY, Fan J, Wu ZQ, Liu YK, Ye SL, Shen ZZ, Xue Q, Zhao Y. Zhonghua Yi Xue Za Zhi; 2005 Nov 30; 85(45):3205-9. PubMed ID: 16405841 [Abstract] [Full Text] [Related]
16. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice]. Zuo CH, Li ZR, Zhou X, Ouyang YZ, Zhou ZY, Zeng L. Ai Zheng; 2006 Apr 30; 25(4):414-20. PubMed ID: 16613672 [Abstract] [Full Text] [Related]
17. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer. Wang L, Chen W, Xie X, He Y, Bai X. Exp Oncol; 2008 Mar 30; 30(1):42-51. PubMed ID: 18438340 [Abstract] [Full Text] [Related]
18. [Inhibition of bladder cancer cell growth and angiogenesis by co-blockage of vascular endothelial growth factor and its receptor KDR]. Chen XL, Liu LC, Xu ZG, Li Z, Li RW, Gao RJ, Wang S, Zhang M, Guo H. Zhonghua Zhong Liu Za Zhi; 2008 Aug 30; 30(8):578-82. PubMed ID: 19102933 [Abstract] [Full Text] [Related]
19. Expression of Inhibitor of Differentiation-1 and Its Effects on Angiogenesis in Gastric Cancer. Li DN, Wang L, Wang L, Li S, Wang YB. Cancer Biother Radiopharm; 2016 Sep 30; 31(7):233-7. PubMed ID: 27610466 [Abstract] [Full Text] [Related]
20. Effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells. Fan YZ, Fu JY, Zhao ZM, Chen CQ. World J Gastroenterol; 2005 Apr 28; 11(16):2431-7. PubMed ID: 15832413 [Abstract] [Full Text] [Related] Page: [Next] [New Search]